Pitavastatin 1 mg daily or 4 mg daily

DRUG2 trials

Sponsors

Juntendo University, Chang Chen

Conditions

Coronary Artery DiseaseNon-Small Cell Lung Cancer

Phase 1

Chemotherapy Plus Pitavastatin Guided by Patient-Derived Tumor-like Cell Clusters in Refractory Non-Small Cell Lung Cancer

Not yet recruitingNCT07351565

Chang ChenNon-Small Cell Lung Cancer

Start: 2026-01-10End: 2026-12-31Target: 22Updated: 2026-01-20

Unknown Phase

Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)

CompletedNCT01042730

Juntendo UniversityCoronary Artery Disease

Start: 2010-02-28End: 2017-11-30Updated: 2021-05-17

Related Papers

Influence of Worsening Renal Function and Baseline Chronic Kidney Disease on Clinical Outcomes in Patients With Chronic Coronary Syndromes: Insights From the REAL‐CAD Study

Journal of the American Heart Association2025-01-174 citations

Significance of Persistent Inflammation in Patients With Chronic Coronary Syndrome: Insights From the REAL-CAD Study.

2024-06-0510 citations

Impact of worsening renal function (WRF) and baseline chronic kidney disease (CKD) on clinical outcomes in patients with chronic coronary syndromes (CCS); insights from the REAL-CAD study

European Heart Journal2023-11-01

Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events

BMC Medicine2022-11-1423 citations

High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)

Circulation2018-05-07230 citations